Records containing: Von Willebrand Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-30A Post-marketing Observational Study to Assess the Efficacy and Safety of the FVIII/VWF Complex (Human), Alphanate®, in Preventing Excessive Bleeding During Surgery in Subjects With Congenital Type 3 Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2026-02-20Clinical Study to Investigate the Efficacy, Pharmacokinetics, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease Patients Under the Age of 6 Years
-
CLINICAL_TRIALS study record update · 2025-04-30A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2025-03-12Molecular and Clinical Profile of Von Willebrand Disease (VWD) in Spain (PCM-EVW-ES). Recruitment Extension, Further Data Analysis, Improvement of Registry Platform, Diagnosis and Management of VWD Application Development
-
CLINICAL_TRIALS study record update · 2024-07-08Evaluation of the Pharmacokinetic Profile, Clinical Efficacy and Safety of the Von Willebrand Factor Contained in FANHDI® (Double-inactivated Human Anti-hemophilic Factor) in Pediatric Subjects With Severe Von Willebrand Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-19Observational Registry of Patients With Von WilLEbrand Disease Treated With Voncento®
-
CLINICAL_TRIALS study record update · 2023-08-25A Post-marketing Observational Study to Assess the Efficacy and Safety of the FVIII/VWF Complex (Human), Alphanate®, in Preventing Excessive Bleeding During Surgery in Subjects With Congenital Type 3 Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2022-06-10Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding
-
CLINICAL_TRIALS study record update · 2021-08-06A PROSPECTIVE, PHASE 3, OPEN-LABEL, INTERNATIONAL MULTICENTER STUDY ON EFFICACY AND SAFETY OF PROPHYLAXIS WITH rVWF IN SEVERE VON WILLEBRAND DISEASE
-
CLINICAL_TRIALS study record update · 2021-05-03Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
-
CLINICAL_TRIALS study record update · 2020-08-17Von Willebrand Disease in the Netherlands - Prospective Study (WiN-Pro)
-
CLINICAL_TRIALS study record update · 2020-02-21Latin-American Von Willebrand Disease Registry
-
CLINICAL_TRIALS study record update · 2019-12-10Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2018-08-08International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
-
CLINICAL_TRIALS study record update · 2018-05-16An Open-label, Multi-centre Post-marketing Study to Assess the Efficacy and Safety of Voncento® in Subjects With Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2018-02-15An Open Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Severe Haemophilia A Patients.
-
CLINICAL_TRIALS study record update · 2017-11-28Phase 1 Study of the Nutraceutical "Hemofix" Safety and Effect on the Coagulation System
-
CLINICAL_TRIALS study record update · 2017-10-06The VWD International Prophylaxis (VIP) Study
-
CLINICAL_TRIALS study record update · 2017-10-03A Phase III Open-label, Multi-centre Study to Assess the Pharmacokinetics, Efficacy, and Safety of Biostate® in Paediatric Subjects With Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2017-10-03An Open-Label, Multi-Centre Extension Study to Assess the Efficacy and Safety of Biostate® in Paediatric, Adolescent, and Adult Subjects With Von Willebrand Disease Who Completed Clinical Studies CSLCT-BIO-08-52 or CSLCTBIO-08-54
-
CLINICAL_TRIALS study record update · 2017-10-03An Open-label, Multi-centre Study to Assess the Pharmacokinetics, Efficacy and Safety of Biostate® in Subjects With Von Willebrand Disease.
-
CLINICAL_TRIALS study record update · 2017-08-31A Phase 3, Prospective, Multicenter Study to Evaluate Efficacy and Safety of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Elective Surgical Procedures in Subjects With Severe Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2017-05-25Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
-
CLINICAL_TRIALS study record update · 2016-05-17Phase II Comparison Study of Hemostatic Efficacy of Escalating Doses of Interleukin-11 (rhIL-11, Neumega) in Subjects With Type 1 Von Willebrand Disease
-
CLINICAL_TRIALS study record update · 2016-04-21A Phase 3 Clinical Study to Determine the Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor : Recombinant Factor VIII (rVWF:rFVIII) and rVWF in the Treatment of Bleeding Episodes in Subjects Diagnosed With Von Willebrand Disease